These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9345046)
1. Molecular mimicry between the rabies virus glycoprotein and human immunodeficiency virus-1 GP120: cross-reacting antibodies induced by rabies vaccination. Bracci L; Ballas SK; Spreafico A; Neri P Blood; 1997 Nov; 90(9):3623-8. PubMed ID: 9345046 [TBL] [Abstract][Full Text] [Related]
2. Binding of HIV-1 gp120 to the nicotinic receptor. Bracci L; Lozzi L; Rustici M; Neri P FEBS Lett; 1992 Oct; 311(2):115-8. PubMed ID: 1397297 [TBL] [Abstract][Full Text] [Related]
3. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency. Turki I; Hammami A; Kharmachi H; Mousli M Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293 [TBL] [Abstract][Full Text] [Related]
4. Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein. Fu ZF; Rupprecht CE; Dietzschold B; Saikumar P; Niu HS; Babka I; Wunner WH; Koprowski H Vaccine; 1993; 11(9):925-8. PubMed ID: 8212838 [TBL] [Abstract][Full Text] [Related]
5. Peptide mimotopes of rabies virus glycoprotein with immunogenic activity. Houimel M; Dellagi K Vaccine; 2009 Jul; 27(34):4648-55. PubMed ID: 19520204 [TBL] [Abstract][Full Text] [Related]
6. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein. van der Heijden RW; Langedijk JP; Groen J; UytdeHaag FG; Meloen RH; Osterhaus AD J Gen Virol; 1993 Aug; 74 ( Pt 8)():1539-45. PubMed ID: 7688410 [TBL] [Abstract][Full Text] [Related]
7. Engineering of a novel zipFv using leucine zipper motif against rabies virus glycoprotein G with improved protection potency in vivo. Xi H; Zhang K; Yin Y; Gu T; Sun Q; Li Z; Cheng Y; Jiang C; Kong W; Wu Y Immunol Lett; 2017 Jun; 186():9-14. PubMed ID: 28389318 [TBL] [Abstract][Full Text] [Related]
8. Molecular mimicry between the rabies virus and human immunodeficiency virus. Bracci L; Neri P Arch Pathol Lab Med; 1995 May; 119(5):391, 393. PubMed ID: 7748062 [No Abstract] [Full Text] [Related]
9. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein. Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400 [TBL] [Abstract][Full Text] [Related]
10. [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus]. Shmarov MM; Tutykhina IL; Logunov DIu; Verkhovskai LV; Nedosekov VV; Tsybanov SZh; Novikov BV; Narodnitskiĭ BS; Gintsburg AL Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):69-71. PubMed ID: 16941876 [TBL] [Abstract][Full Text] [Related]
11. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds. Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646 [TBL] [Abstract][Full Text] [Related]
12. Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine? Drings A; Jallet C; Chambert B; Tordo N; Perrin P Vaccine; 1999 Mar; 17(11-12):1549-57. PubMed ID: 10195792 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. Moore JP; Ho DD J Virol; 1993 Feb; 67(2):863-75. PubMed ID: 7678308 [TBL] [Abstract][Full Text] [Related]
14. Sequence homology between HIV gp120, rabies virus glycoprotein, and snake venom neurotoxins. Is the nicotinic acetylcholine receptor an HIV receptor? Neri P; Bracci L; Rustici M; Santucci A Arch Virol; 1990; 114(3-4):265-9. PubMed ID: 2241576 [No Abstract] [Full Text] [Related]
15. Canine vaccine recipients recognize an immunodominant region of the rabies virus glycoprotein. Johnson N; Mansfield KL; Fooks AR J Gen Virol; 2002 Nov; 83(Pt 11):2663-2669. PubMed ID: 12388801 [TBL] [Abstract][Full Text] [Related]
16. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice. Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673 [TBL] [Abstract][Full Text] [Related]
17. Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57. Duan Y; Gu T; Zhang X; Jiang C; Yuan R; Li Z; Wang D; Chen X; Wu C; Chen Y; Wu Y; Kong W Mol Immunol; 2014 Jun; 59(2):136-41. PubMed ID: 24598312 [TBL] [Abstract][Full Text] [Related]
18. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies. Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942 [TBL] [Abstract][Full Text] [Related]
19. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus. Wang Y; Xiang Z; Pasquini S; Ertl HC J Virol; 1998 Mar; 72(3):1790-6. PubMed ID: 9499029 [TBL] [Abstract][Full Text] [Related]